These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 1696820)
1. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase. Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950 [TBL] [Abstract][Full Text] [Related]
3. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Hatzelmann A; Tenor H; Schudt C Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697 [TBL] [Abstract][Full Text] [Related]
5. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes. Elks ML; Manganiello VC Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009 [TBL] [Abstract][Full Text] [Related]
6. Chemoattractant-induced release of elastase by tumor necrosis factor-primed human neutrophils: auto-regulation by endogenous adenosine. Ottonello L; Amelotti M; Barbera P; Dapino P; Mancini M; Tortolina G; Dallegri F Inflamm Res; 1999 Dec; 48(12):637-42. PubMed ID: 10669115 [TBL] [Abstract][Full Text] [Related]
7. Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes. Nicholson D; White TD; Sawynok J Can J Physiol Pharmacol; 1991 Jun; 69(6):877-85. PubMed ID: 1717120 [TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism. Zhu WH; Majluf-Cruz A; Omburo GA Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes. Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. Souness JE; Hassall GA; Parrott DP Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964 [TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. Denis D; Riendeau D Eur J Pharmacol; 1999 Feb; 367(2-3):343-50. PubMed ID: 10079010 [TBL] [Abstract][Full Text] [Related]
12. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction. Muller B; Lugnier C; Stoclet JC J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603 [TBL] [Abstract][Full Text] [Related]
13. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim. Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362 [TBL] [Abstract][Full Text] [Related]
14. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Lavan BE; Lakey T; Houslay MD Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089 [TBL] [Abstract][Full Text] [Related]
16. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram. Michie AM; Lobban M; Müller T; Harnett MM; Houslay MD Cell Signal; 1996 Feb; 8(2):97-110. PubMed ID: 8730511 [TBL] [Abstract][Full Text] [Related]
17. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone. Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594 [TBL] [Abstract][Full Text] [Related]